Early Proactive Therapeutic Drug Monitoring of Infliximab in Children: EPIC Study

Clinical trial NCT05280405 · UNKNOWN

Trial details

NCT number: NCT05280405
Sponsor: IRCCS Burlo Garofolo
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases

Start date: 2022-03-09
Primary completion: 2024-01-31
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.